Srinivasaraghavan Nivedhyaa, Seshadri Ramakrishnan Ayloor, Ramasamy Yogesh, Raj Pritha, Chockalingam Punitha, Sankar P R Pravin, Modh Vallary, Ramakrishnan Balasubramaniam
From the Department of Anesthesia and Critical Care, Cancer Institute (WIA), Chennai, Tamil Nadu, India.
Consultant Surgical Oncologist, Integrated Cancer Care Group, Chennai, Tamil Nadu, India.
A A Pract. 2025 Jul 23;19(7):e02019. doi: 10.1213/XAA.0000000000002019. eCollection 2025 Jul 1.
The management of postoperative pain after upper abdominal surgery is challenging. Thoracic epidural analgesia, though effective, has limitations, while intravenous (IV) morphine is associated with side effects. Ultrasound-guided external oblique intercostal block (EOIB) is an emerging regional technique for upper abdominal pain relief. We hypothesized that EOIB would provide superior pain relief to IV morphine in patients undergoing upper abdominal surgery. The main objective of the study was to compare pain relief from EOIB versus IV morphine as rescue analgesia in patients with moderate to severe pain despite an epidural after upper abdominal surgeries.
This double-blinded, randomized controlled trial was conducted at a tertiary cancer hospital from January to November 2024. Patients aged ≥18 years undergoing upper abdominal surgery with pain on the numerical rating scale ≥4 despite epidural and IV paracetamol were randomized (1:1) to IV morphine (0.05 mg/kg, Arm A) or bilateral EOIB (0.1% bupivacaine 1 mL/kg and 4 mg dexamethasone, Arm B). The primary outcome was the total 24-hour morphine rescue requirement. Secondary outcomes included pain intensity difference (PID) at 0.5, 1, 4, 8, 12, 16, 20, and 24 hours, summated pain intensity difference at 8 and 24 hours (SPID), percentage PID in the first four hours, pain-free hours (PFH), and adverse events. Participants and outcome assessor nurses were blinded in the trial.
Of 101 screened patients, 66 were randomized with 33 in each group. The EOIB arm had significantly lower 24-hour morphine requirements compared to the morphine arm median (interquartile range) 0 mg (0-1.5) vs 2.5 mg (1-6.1), respectively; median difference (95% confidence interval [CI], 1.5 [0.00-3.40]; P = .006). Repeated measures analysis of variance with Greenhouse-Geisser correction determined that the mean PID did not differ among the two groups across different time points over 24 hours; F (7,434) = 1.08, P = .37. SPID at 8 and 24 hours favored EOIB (P = .038 and P = .048, respectively). The percentage PID in the first four hours was higher in the EOIB arm than morphine arm, 66.6% [58.5%-100%] vs 50% [34.9%-74%]; P = .002. PFH was significantly higher in the EOIB arm than morphine arm 4.00 [0.00-8.00] hours vs 0.00[0.00-0.37] hours; P = .015, with two patients achieving complete pain relief (NRS = 0) for 24 hours, compared to none in the IV morphine group. No significant adverse events were observed.
EOIB provided superior and prolonged analgesia compared to IV morphine as a supplement to epidural analgesia, reducing opioid consumption and increasing the pain-free period in patients undergoing upper abdominal surgery.
上腹部手术后的疼痛管理具有挑战性。胸段硬膜外镇痛虽然有效,但存在局限性,而静脉注射吗啡会产生副作用。超声引导下的腹外斜肌肋间阻滞(EOIB)是一种新兴的用于缓解上腹部疼痛的区域技术。我们假设,对于接受上腹部手术的患者,EOIB在缓解疼痛方面将优于静脉注射吗啡。本研究的主要目的是比较在接受上腹部手术后尽管使用了硬膜外镇痛但仍有中度至重度疼痛的患者中,EOIB与静脉注射吗啡作为补救性镇痛措施在缓解疼痛方面的效果。
本双盲、随机对照试验于2024年1月至11月在一家三级癌症医院进行。年龄≥18岁、接受上腹部手术且尽管使用了硬膜外镇痛和静脉注射对乙酰氨基酚但数字评分量表上的疼痛评分≥4的患者被随机分组(1:1),分别接受静脉注射吗啡(0.05 mg/kg,A组)或双侧EOIB(0.1%布比卡因1 mL/kg和4 mg地塞米松,B组)。主要结局是24小时吗啡补救需求量。次要结局包括0.5、1、4、8、12、16、20和24小时的疼痛强度差值(PID)、8小时和24小时的累积疼痛强度差值(SPID)、前四小时的PID百分比、无痛小时数(PFH)以及不良事件。试验中参与者和结局评估护士均为盲法。
在101名筛查患者中,66名被随机分组,每组33名。与吗啡组相比,EOIB组24小时吗啡需求量显著更低,中位数(四分位间距)分别为0 mg(0 - 1.5)和2.5 mg(1 - 6.1);中位数差值(95%置信区间[CI],1.5[0.00 - 3.40];P = 0.006)。采用Greenhouse-Geisser校正的重复测量方差分析确定,在24小时内不同时间点,两组的平均PID无差异;F(7,434) = 1.08,P = 0.37。8小时和24小时的SPID有利于EOIB组(分别为P = 0.038和P = 0.048)。EOIB组前四小时的PID百分比高于吗啡组,分别为66.6%[58.5% - 100%]和50%[34.9% - 74%];P = 0.002。EOIB组的PFH显著高于吗啡组,分别为4.00[0.00 - 8.00]小时和0.00[0.00 - 0.37]小时;P = 0.015,有两名患者实现了24小时完全无痛(数字评分量表 = 0),而静脉注射吗啡组无此情况。未观察到显著的不良事件。
作为硬膜外镇痛的补充,与静脉注射吗啡相比,EOIB提供了更优且更持久的镇痛效果,减少了阿片类药物的消耗,并增加了接受上腹部手术患者的无痛时长。